Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > KG > Summary

King Pharmaceuticals Inc.
(KG)

11.44USD   Up0.14 (1.24%)   
At 2:32AM IST
 King Pharmaceuticals Inc. (NYSE:KG) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 11.44USD
Trade Time:2:32AM IST
Change:Up0.14 (1.24%)
Prev Close:11.30
Open:11.41
Bid:N/A
Ask:N/A
1y Target Est:12.88
Day's Range:11.28 - 11.55
52wk Range:5.86 - 13.20
Volume:3,200,013
Avg Vol (3m):2,859,660
Market Cap:2.84B
P/E (ttm):N/A
EPS (ttm):-1.93
Div & Yield:N/A (N/A%)
Add KG to Portfolio   Download Data

HEADLINES

 
•King Pharmaceuticals Appoints Two New Members to Its Board of Directors - Marketwire  - Wed 3:25AM
•King Launches PainBalance(R): Educational Initiative to Help Reduce the Burden of Pain - PR Newswire  - Wed, Feb 3
•Coverage initiated on King Pharms by Jefferies & Co - Briefing.com  - Tue, Feb 2
•Why Pharma Is Pushing Its Drug Pushers Out - Minyanville.com  - Fri, Jan 22
•UPDATE - King Pharmaceuticals reviews animal health unit - Reuters  - Fri, Jan 15
•KING PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure - EDGAR Online  - Fri, Jan 15
•King Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire  - Wed, Jan 6
•King Pharmaceuticals: A Look Ahead to Dec 2009 Quarterly Results - Seeking Alpha  - Thu, Dec 31
•[video] Stealth Generic Drug Play: 1 Minute Trade - TheStreet.com  - Fri, Dec 11
•ZymoGenetics claims court win versus King - bizjournals.com  - Fri, Dec 11
•KING PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers - EDGAR Online  - Thu, Dec 10
» More Headlines for KG...

ANALYST

 
EPS Est (next year) (Dec-09) :1.08
EPS Est (in 2 years) (Dec-10) :1.02
Avg Rec (current)*:1.8
PEG Ratio:1.72
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
King Pharmaceuticals, Inc. research and develops, manufactures, markets, and sells branded prescription pharmaceutical products and animal health products worldwide.

» Full Company Profile